Eric Coldwell
Stock Analyst at Baird
(5.00)
# 15
Out of 4,906 analysts
193
Total ratings
55.56%
Success rate
120.19%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Neutral | $9 → $10 | $8.18 | +22.25% | 18 | Jun 6, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $22 | $21.18 | +3.87% | 8 | May 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $162.61 | -13.90% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $188.87 | -14.76% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $158.97 | +0.65% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $157.56 | +7.90% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $251.56 | +6.14% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $477.40 | -34.44% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $177.28 | +9.43% | 10 | Apr 23, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $9.41 | +70.03% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $5.86 | +326.62% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $708.02 | -2.83% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.54 | +342.13% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $60.53 | -25.65% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $60.97 | +8.26% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.56 | +2,848.72% | 4 | Nov 10, 2017 |
Owens & Minor
Jun 6, 2025
Maintains: Neutral
Price Target: $9 → $10
Current: $8.18
Upside: +22.25%
Premier
May 15, 2025
Maintains: Neutral
Price Target: $19 → $22
Current: $21.18
Upside: +3.87%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $162.61
Upside: -13.90%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $188.87
Upside: -14.76%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $158.97
Upside: +0.65%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $157.56
Upside: +7.90%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $251.56
Upside: +6.14%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $477.40
Upside: -34.44%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $177.28
Upside: +9.43%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.41
Upside: +70.03%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $5.86
Upside: +326.62%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $708.02
Upside: -2.83%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.54
Upside: +342.13%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $60.53
Upside: -25.65%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $60.97
Upside: +8.26%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.56
Upside: +2,848.72%